Preferred Plus Mucus Er
Loading...Preferred Plus Mucus Er Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
- •
- for children under 12 years of age
- •
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- •
- cough accompanied by too much phlegm (mucus)
- •
- cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
- •
- for children under 12 years of age
- •
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- •
- cough accompanied by too much phlegm (mucus)
- •
- cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Preferred Plus Mucus Er Manufacturers
-
Kinray
![Preferred Plus Mucus Er (Guaifenesin) Tablet, Extended Release [Kinray]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Preferred Plus Mucus Er | Basiem
DOSAGE AND ADMINISTRATIONFor most patients, the recommended dose of cyclobenzaprine hydrochloride tablets, USP is 5 mg three times a day. Based on individual patient response, the dose may be increased to 10 mg three times a day. Use of cyclobenzaprine hydrochloride tablets, USP for periods longer than two or three weeks is not recommended (see INDICATIONS AND USAGE).
DOSAGE AND ADMINISTRATION
Less frequent dosing should be considered for hepatically impaired or elderly patients (see PRECAUTIONS, Impaired Hepatic Function, and Use in the Elderly).Apply MaC Patch to intact skin to cover the area most sensitive to pain. Each patch should not be applied for more than 8 hours in a given 24-hour period. Patches may be cut into smaller sizes with scissors prior to removal of the release liner. Clothing may be worn over the area of application. Smaller areas of treatment are recommended in a debilitated patient, or a patient with impaired elimination.
If irritation or a burning sensation occurs during application, remove the patch and do not reapply until the irritation subsides. When MaC Patch is used concomitantly with other products containing same or similar agents, the amount absorbed from all formulations must be considered
Login To Your Free Account